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IMPACT OF BODY MASS INDEX AND WEIGHT CHANGE ON RISK OF RECURRENCE IN 
PATIENTS TREATED FOR ENDOMETRIAL ADENOCARCINOMA 
 
Geneva A. DeGregorio, BA; Katherine G. Leung, MPH; Leslie S. Bradford, MD 
Department of Obstetrics and Gynecology, University of Massachusetts Medical School 
 
Background: Obesity is a well-documented risk factor for EAC, but the relationship between 
obesity and disease recurrence is controversial. Additionally, body weight is an inherently 
dynamic variable and no studies have examined the relationship between interval weight 
change and risk of EAC recurrence. 
 
Objectives: To identify if there is a relationship between body mass index (BMI) or interval 
weight change and the risk of disease recurrence among women treated for EAC.  
 
Methods: We conducted a retrospective chart review of 337 women diagnosed and treated 
surgically for EAC at UMass Memorial Medical Center from 2010 to 2015. The effect of BMI on 
risk of disease recurrence was assessed by Cox proportional hazards model adjusting for age, 
FIGO stage, myometrial invasion, lymphovascular space involvement and status of adjuvant 
therapy. The effect of interval weight change on EAC recurrence was assessed using logistic 
regression, adjusting for BMI and recurrence free interval.  
 
Results: Among 337 women diagnosed with EAC, mean BMI at diagnosis was 35.9 pounds 
(SD: 8.9), mean weight at diagnosis was 201.5 pounds (SD: 52.7) and mean interval weight 
change was -8.1 pounds (SD: 18.8). At time of data extraction there were 19 patients (5.7%) 
with disease recurrence. The hazard ratio for recurrence in women with BMI >50 was 11.4 
[95%CI: 1.54-84.05] times that of women with BMI<30 (p=0.02). Women who maintained or 
gained weight following primary surgical resection had no increased risk of recurrence 
compared to those who lost weight [OR: 1.02, 95%CI: 0.27-3.82] (p=0.97). 
 
Conclusion: Women with extreme obesity at diagnosis are more likely to have disease 
recurrence following primary surgical treatment for endometrial adenocarcinoma. However, 
women who lose weight following primary surgical treatment of EAC are just as likely to have 
disease recurrence as those who maintain or gain weight.  
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